Study links genetics to GLP-1 weight loss drug effectiveness.

Novo Nordisk partners with OpenAI to use AI for faster drug discovery and lower costs.

India targets global pharma leadership through innovation initiatives.

Revolution Medicines' daraxonrasib shows promising results in pancreatic cancer trial.

Amazon Pharmacy stocks Eli Lilly's weight-loss pill Foundayo at clinics for same-day delivery.

Telix and Regeneron partner to develop radiopharmaceutical therapies for solid tumors.

NZ expands cancer care with $814M investment for 13,000 new infusions.

FDA approves first FSGS treatment for patients 8+ without nephrotic syndrome.

Oxford scientists created an AI tool predicting heart failure risk five years in advance with high accuracy.

Study finds psychedelics create consistent brain reorganization.